The Aflac Cancer Center has some of the nation’s lowest mortality rates 100 days after BMT for allogeneic transplants. Low mortality rates means that most patients are doing well after their BMTs. We always work toward a 0 percent mortality rate, which we achieved in 2012 for autologous transplants.
What does this data mean?
The graph shows the mortality rates for patients 100 days after their BMTs, compared to a benchmark.*
Why is this important?
Patient mortality rates show the success of a pediatric cancer center. Low mortality rates means that most patients are doing well after their BMTs. We always work toward a 0 percent mortality rate at the Aflac Cancer Center.
How does the Aflac Cancer Center help ensure we are providing high-quality care?
- Our pediatric BMT team works together to help ensure our patients receive the best donor match possible.
- Family support team, including child life specialists who educate children and families about what to expect before, during and after a BMT
- The inpatient unit has 10 specially designed, high efficiency particulate air (HEPA)-filtered rooms, as well as a playroom just for BMT patients.
- The HEPA-filtered BMT outpatient suite has five private rooms for infusions, treatments and exams.
- We are accredited by the Foundation for the Accreditation of Cellular Therapy (FACT), making the Aflac Cancer Center the only FACT-accredited pediatric BMT center in Georgia.
- Our patients have access to more than 300 clinical trials, affording the access to some of the most novel treatment options in the country
*Source: Internally derived benchmarks based on review of national registry data for 2012.